loading

Replimune Group Inc Azioni (REPL) Dati Finanziari

Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
Data di fine periodo 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Durata del periodo 3 mesi 3 mesi 3 mesi 3 mesi 3 mesi
Revenues
-
- - - -
Operating Expenses
14.74%
71.87
84.29 90.42 79.33 66.02
Operating Income/Loss
14.74%
-71.87
-84.29 -90.42 -79.33 -66.02
Nonoperating Income/Loss
47.36%
0.627
1.191 3.729 5.091 0.254
Income/Loss From Continuing Operations Before Tax
14.27%
-71.24
-83.10 -86.69 -74.24 -65.77
Income Tax Expense/Benefit
-0.311
- - -0.107 0.575
Income/Loss From Continuing Operations After Tax
14.65%
-70.93
-83.10 -86.69 -73.66 -66.34
Net Income/Loss
14.65%
-70.93
-83.10 -86.69 -74.13 -66.34
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.30%
92.19
91.92 91.52 3.4505 83.50
Diluted Average Shares
0.30%
92.19
91.92 91.52 3.4505 83.50
Basic Earnings Per Share
14.44%
-0.77
-0.90 -0.95 -0.82 -0.79
Diluted Earnings Per Share
14.44%
-0.77
-0.90 -0.95 -0.82 -0.79
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$45.65
price down icon 0.48%
$28.06
price down icon 1.72%
$52.56
price down icon 1.55%
$91.19
price up icon 1.21%
$139.50
price down icon 0.01%
biotechnology ONC
$284.05
price down icon 0.44%
Capitalizzazione:     |  Volume (24 ore):